ADHD Trial, Recruiting NCT06378281 Sponsor: Stéphanie Baggio Condition: ADHD
Back to Adhd

ADHD Trial, Recruiting

NCT06378281
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must already be taking part in the related main ("parent") clinical trial
  • You must be 18 years old or older
  • You must have a good understanding of the French language
  • You must not currently have an acute (sudden or severe) psychiatric disorder
  • You must have already signed a written consent form to take part in the related main clinical trial

Who may not be able to join:

  • There are no additional exclusion criteria listed for this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +41216923238

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Stéphanie Baggio
Registry
ClinicalTrials.gov
Start date
1 May 2024
Est. completion
30 September 2026

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Understanding of the informed consent (binary)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov